Viking Global Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.21B |
| 2 |
Labcorp
LH
|
+$608M |
| 3 |
Elevance Health
ELV
|
+$602M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$575M |
| 5 |
Netflix
NFLX
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$661M |
| 2 |
MetLife
MET
|
+$660M |
| 3 |
Cigna
CI
|
+$472M |
| 4 |
Mohawk Industries
MHK
|
+$462M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.42% |
| 2 | Consumer Discretionary | 14.42% |
| 3 | Communication Services | 11.15% |
| 4 | Financials | 8.97% |
| 5 | Materials | 7.21% |
Similar funds
Viking Global Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Viking Global Investors held 78 positions worth $26.1B, down 1.4% from $26.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Viking Global Investors deployed $1.92B of net new capital in Q3 2015, opening 23 new positions and adding to 19 existing holdings. Its largest new stake was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Illumina, an estimated $661M trimmed.
- Viking Global Investors's largest Q3 2015 buy was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
- Viking Global Investors added most to Elevance Health in Q3 2015, an estimated $602M increase.
- Viking Global Investors's biggest Q3 2015 reduction was Illumina, cutting an estimated $661M.
- Viking Global Investors fully exited MetLife in Q3 2015, selling an estimated $660M.
- Viking Global Investors's ten largest holdings make up 52% of its $26.1B portfolio in Q3 2015.
- Viking Global Investors opened 23 new positions and closed 16 in Q3 2015.
- Viking Global Investors's portfolio value fell 1.4% quarter-over-quarter to $26.1B.
Based on Viking Global Investors's 13F filing for Q3 2015, filed 16 Nov 2015.